Article

Questions for Medicare in Meningitis Outbreak

Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The giant health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the Food and Drug Administration as safety risks. In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease.

Read the full story: http:/bit.ly/OQziq3

Source: The Associated Press

Related Videos
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Dr Andrew S. Oseran
Dr Maria DeYoreo
Dr Maria DeYoreo
Dr Maria DeYoreo
dr carol regueiro
Related Content
Person pushing button with slight frowning face | Image credit: EDER – stock.adobe.com
March 11th 2025

Americans Give US Health Care System a C Grade, Calling for Policy Change

Hayden E. Klein
A new report shows most Americans believe the government is too involved in health care regulation and want to see a ban on pharmaceutical company advertisements in the US.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Dermatology illustration | Image Credit: ibreakstock - stock.adobe.com
March 7th 2025

Shaping Dermatology's Future by Increasing Access, Data, and Advocacy

Brooke McCormick
Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
managed care cast logo
January 28th 2025

The Evolving Annual Wellness Visit

Laura Joszt, MA Christopher Wheelock, MD
The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.
The report estimates that the loss of enhanced PTCs would lead to a $26.1 billion reduction in federal tax credits given to individuals, health insurers, and in turn, health care providers. | Image credit: onephoto - stock.adobe.com
March 6th 2025

Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates

Rose McNulty
Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
AJMC
March 5th 2025

Facilitators of and Barriers to Medicaid Investment in Electronic Consultation Services

Julie E. Kim, MD Libby Sagara, BA Alison M. DeDent, MD, MAS Delphine S. Tuot, MDCM, MAS
In this qualitative investigation, leaders of Medicaid managed care plans were interviewed to identify facilitators of and barriers to electronic consultation for specialty care delivery.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo